Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 5873 - 5880 of 12143 results

Immigration Attys Brace For Surging I-9 Audits

August 30, 2018| News

Managing your CEO’s social media habits

August 28, 2018| News

I-9 Audits and Investigations of Employers Have Nearly Quadrupled in 2018

August 28, 2018| Blog| Viewpoint

House and Senate Opioid Packages Comparison

August 28, 2018| Blog| Viewpoint

F-Squared Was Wrong Test Case For SEC Disgorgement

August 28, 2018| News

Premium Processing Suspension Extended and Expanded for H-1B Petitions as of September 11, 2018

August 28, 2018| Alert| Viewpoint

President Signs Legislation Reforming CFIUS & Export Controls

August 28, 2018| Alert| Viewpoint

The Form is Always Wrong

August 27, 2018| Article| Viewpoint

News & Press Releases

Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash

September 16, 2025

Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.

Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber

September 15, 2025

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

View all News and Press Releases